Puja Mehta

University College London Hospitals NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

30h-index13.8kcitations118works16.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Long-Term Effects of COVID-19(27), COVID-19 Clinical Research Studies(26), SARS-CoV-2 and COVID-19 Research(13), Inflammasome and immune disorders(12), Chronic Obstructive Pulmonary Disease (COPD) Research(10)

Publications104 total

Social media in advancing equity and collaboration in rheumatology: the CORDIALITY review
RMD Open·2025· 3 citedOpen Access
The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis
ERJ Open Research·2024Open Access
A Rare Case of Ectopic Splenic Transplantation in a 16 Year Old with Hereditary Spherocytosis
Blood·2024Open Access
S80 The post-covid lung microbiome resembles that of healthy volunteers. Insights from the POST COVID-19 interstitial lung DiseasE (postcode) study
2024
S79 BAL lymphocytosis is associated with a higher predicted FVC in patients with persistent residual lung abnormalities after COVID-19
2024
Human SARS-CoV-2 challenge uncovers differences in local and systemic cellular responses associated with protection from infection and distinct infection states
2024
Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Nature·2024· 2 citedOpen Access
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Nature·2024· 103 citedOpen Access
Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection
Nature Microbiology·2024· 1 citedOpen Access
Single-cell analysis of bronchoalveolar cells in inflammatory and fibrotic post-COVID lung disease
Frontiers in Immunology·2024· 9 citedOpen Access
Age-specific nasal epithelial responses to SARS-CoV-2 infection
Nature Microbiology·2024· 43 citedOpen Access
Residual Lung Abnormality Following COVID-19 Hospitalisation is Characterised by Epithelial Injury
SSRN Electronic Journal·2024Open Access
Iatrogenic HLH
Advances in experimental medicine and biology·2024
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope
Rheumatology Advances in Practice·2024· 5 citedOpen Access
Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)
Thorax·2023· 17 citedOpen Access
Lymphadenopathy in the rheumatology practice: a pragmatic approach
Lara D. Veeken·2023· 27 citedOpen Access
S84 Single-cell landscape of bronchoalveolar cells in inflammatory and fibrotic post-COVID residual lung abnormalities
2023Open Access
S73 Single cell RNA sequencing of PBMCs reveals differences between fast and slow resolving post-COVID interstitial lung disease
2023Open Access
Late Breaking Abstract - Single-cell landscape of bronchoalveolar cells in inflammatory and fibrotic post-COVID residual lung abnormalities
2023· 1 cited
Should race be considered in diagnosing giant cell arteritis? – Authors' reply
The Lancet Rheumatology·2023
page 1 of 6Next →

Frequent Co-authors

Rachel C. Chambers(14), Joanna C. Porter(10), Masahiro Yoshida(7), Kaylee B. Worlock(7), Rik G.H. Lindeboom(6), Lira Mamanova(6), Liam Bolt(6), Krzysztof Polański(6), Marko Nikolić(6), Kerstin B. Meyer(6), Coziana Ciurtin(6), Jessica Manson(5), Ni Huang(5), Anna Wilbrey-Clark(5), Elena Prigmore(5), Claire M. Smith(5), Sarah A. Teichmann(5), Richard Conway(5), Emma Denneny(5), Melissa Heightman(5)